Oncolytics also recently expanded its Scientific Advisory Board with globally recognized experts from Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center, positioning the company for ...
Drugmaker CEOs see sales online channels as a budding opportunity, while some biotech investors told BioPharma Dive to expect ...
An inconsistent boom-and-bust cycle funding environment for early-stage biotech innovations and burdensome regulation ...
The Chosun Ilbo on MSN
Oral obesity treatments target 30% market by 2030
At the JP Morgan Healthcare Conference (JPMHC), global pharmaceutical and biotech companies unveiled their research and ...
Stock sales from drug developers are off to a flying start on US exchanges in 2026, boosting the prospects for biotechnology ...
The enormous ocean-to-lake compound, which is owned by biotech billionaire Randal J. Kirk, first hit the market for $134 ...
Acadia Pharma’s Catherine Owen Adams has formed a group of small- to mid-cap biotechs to advocate against a ‘peanut butter ...
The growing complexity of pharmaceutical and biotech innovation has placed unprecedented pressure on life science recruiters ...
France's Finance Ministry said on Monday it had received no formal request for investment approval regarding French biotech ...
Mahoney brings deep market expertise to guide biotech and pharmaceutical occupiers ...
In other news, on December 30, Ultragenyx Pharmaceutical completed its rolling BLA submission to the FDA for DTX401, which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback